Lomustine
Spezifikationen
13010-47-4CAS-Nummer
235-859-2EG-Nummer
1-(2-chloroethyl)-3-cyclohexyl-1-nitrosoureaIUPAC-Name
C9H16ClN3O2Chemische Formel
233.69 g/molMolekulargewicht
lomustine; 13010-47-4; 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea; Belustine; CCNU; CeeNU; Cecenu; CINU; Chloroethylcyclohexylnitrosourea; Urea, N-(2-chloroethyl)-N'-cyclohexyl-N-nitroso-; Lomustina; N-(2-Chloroethyl)-N'-cyclohexyl-N-nitrosourea; Lomustinum; NSC-79037; Gleostine; Cyclohexyl chloroethyl nitrosourea; 1-(2-Chloroethyl)-3-cyclohexylnitrosourea; NSC 79037; ICIG 1109; NCI-C04740; NSC79037; DTXSID2023222; (Chloro-2-ethyl)-1-cyclohexyl-3-nitrosourea; RB 1509; (Cloro-2-etil)-1-cicloesil-3-nitrosourea; CCN-U; 1-Nitrosourea, 1-(2-chloroethyl)-3-cyclohexyl-; 7BRF0Z81KG; 3-(2-chloroethyl)-1-cyclohexyl-3-nitrosourea; CHEBI:6520; DTXCID103222; 2-chloro-N-(cyclohexyl-C-hydroxycarbonimidoyl)-N-nitrosoethan-1-amine; Lomeblastin; Belustin; Lucostin; Lucostine; Prava; RefChem:55515; chloroethylcyclo-hexylnitrosourea; L01AD02; RB-1509; WR-139017; 235-859-2; Citostal; Lomustinum [INN-Latin]; Lomustina [INN-Spanish]; SRI 2200; MFCD00012392; Lomustine (CeeNU); Urea, 1-(2-chloroethyl)-3-cyclohexyl-1-nitroso-; CCNU; NSC 79037; s1840; NCGC00167466-01; CCRIS 860; CAS-13010-47-4; CCNU [Chloroethyl nitrosoureas]; HSDB 6519; SR-05000001497; EINECS 235-859-2; UNII-7BRF0Z81KG; BRN 2125058; Lomustine; 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea; (Cloro-2-etil)-1-cicloesil-3-nitrosourea [Italian]; Lomustine [USAN:INN:BAN]; AI3-52779; Lomustine CRS; Gleostine (TN); Lomustine (Standard); Lomustine, >=98%; LOMUSTINE [INN]; LOMUSTINE [MI]; LOMUSTINE [HSDB]; LOMUSTINE [USAN]; LOMUSTINE [VANDF]; 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea [Chloroethyl nitrosoureas]; CHEMBL514; LOMUSTINE [MART.]; NCIMech_000220; LOMUSTINE [USP-RS]; LOMUSTINE [WHO-DD]; SCHEMBL3995; 1-(2-chloroethyl)-3-cyclohexyl-1-nitroso-urea; Lomustine (JAN/USP/INN); Lomustine - Bio-X trade mark; WLN: L6TJ AMVNNO&2G; GTPL7214; orb1308063; LOMUSTINE [ORANGE BOOK]; LOMUSTINE [EP MONOGRAPH]; LOMUSTINE [USP MONOGRAPH]; GLXC-05868; HMS2090A17; HMS3655I16; HMS5080A15; Pharmakon1600-01502301; Tox21_112470; BDBM50247919; EBC-11125; HY-13669R; NSC759635; AKOS005766022; Tox21_112470_1; AC-8062; CCG-213022; CS-1461; DB01206; DS-1269; FL24923; NSC-759635; NCGC00167466-02; NCGC00167466-03; NCGC00167466-10; BL164634; HY-13669; NCI60_041743; DB-017097; L5648; NS00003479; SW220040-1; C07079; D00363; EN300-118685; AB00173884-02; AB00173884-03; AB00173884-04; AB00173884_05; AB00173884_06; F036500; Q415378; SR-05000001497-1; SR-05000001497-3; Urea, 1-(2-chloroethyl)-3-cyclohexyl)-1-nitroso-; Lomustine Working Standard (Secondary Reference Standard); Lomustine, European Pharmacopoeia (EP) Reference Standard; 1-(2-CHLOROETHYL)-3-CYCLOHEXYL-1-NITROSOUREA [IARC]; Lomustine, United States Pharmacopeia (USP) Reference Standard; 1-(2-Chloroethyl)-1-[(cyclohexylamino)carbonyl]-2-oxohydrazine #Synonyme
